SciELO - Scientific Electronic Library Online

 
vol.4 número7EXOESQUELETOS PARA POTENCIAR LAS CAPACIDADES HUMANAS Y APOYAR LA REHABILITACIÓN índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Ingeniería Biomédica

versión impresa ISSN 1909-9762

Resumen

GARCIA QUIROZ, Felipe  y  SINCLAIR, S. Michael. ENGINEERING ANTIBODY FRAGMENTS: REPLICATING THE IMMUNE SYSTEM AND BEYOND. Rev. ing. biomed. [online]. 2010, vol.4, n.7, pp.74-86. ISSN 1909-9762.

Since genetic engineering of humanized murine monoclonal antibodies was first demonstrated over two decades ago, antibody engineering technologies have evolved based upon an increasing understanding of the mechanisms involved in antibody generation in vivo, and a constant search for alternative routes to evolve and exploit the characteristics of antibodies. As a result, antibody engineers have devised innovative strategies for the rapid evolution and selection of antibodies and novel antibody designs (i.e., antibody fragments). Phage display, cell display and ribosome display technologies, which comprise the core of the currently available technologies for the discovery and preparation of such antibodies, are reviewed herein. This article intends to communicate the state-of-the-art technology available for the engineering of antibodies to a general readership interested in this important field. Therefore, important immunology concepts are introduced before detailed descriptions of the three antibody engineering technologies are presented in later sections. A comparison of these methodologies suggests that despite the predominance of phage display for the engineering of antibody fragments in the past 20 years, cell display and ribosome display will likely gain importance in the selection and discovery of the antibody fragments in the future. Finally, these technologies are likely to play an important role in the production of the next generation of antibody-based therapeutics.

Palabras clave : Antibody engineering; Phase display; Cell display; Ribosome display; Antibody humanization.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )